Baseline Demographics and Disease Characteristics from ORATORIO, a Phase III Trial Evaluating Ocrelizumab in Patients with Primary Progressive Multiple Sclerosis

被引:0
|
作者
Montalban, X. [1 ]
Hemmer, B. [2 ]
Rammohan, K. [3 ]
Giovannoni, G. [4 ]
de Seze, J. [5 ]
Bar-Or, A. [6 ]
Arnold, D. [6 ]
Sauter, A. [7 ]
Leppert, D. [8 ]
Chin, P. [9 ]
Garren, H. [8 ]
Messier, M. [8 ]
Wolinski, J. [10 ]
Kakarieka, A. [8 ]
Masterman, D. [9 ]
机构
[1] Vall dHebron Univ Hosp, Dept Neurol Neuroimmunol, Barcelona, Spain
[2] Tech Univ Munich, Neurol, D-80290 Munich, Germany
[3] Univ Miami Hlth Syst, MS Ctr Excellence, Miami, FL USA
[4] Barts & London Queen Marys Sch Med & Dent, Neurosci, London, England
[5] Univ Hosp Strasbourg, Neurol, Strasbourg, France
[6] McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada
[7] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
[8] F Hoffmann La Roche & Co Ltd, Neurosci, CH-4002 Basel, Switzerland
[9] Genentech Roche, Neurosci, San Francisco, CA USA
[10] Univ Texas Houston, Sch Med, Neurosci, Houston, TX USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
F3049
引用
收藏
页码:706 / 706
页数:1
相关论文
共 50 条
  • [41] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Craveiro, L.
    Hughes, R.
    Prajapati, K.
    Koendgen, H.
    Pradhan, A.
    Wolinsky, J. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 331 - 331
  • [42] SOCIOECONOMIC VALUE OF OCRELIZUMAB IN THE TREATMENT OF PATIENTS WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
    Di Maio, D.
    Liu, C.
    Marcelli, G.
    Alvarez, Sanchez J.
    Overell, J.
    VALUE IN HEALTH, 2020, 23 : S632 - S633
  • [43] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, Stephen L.
    Kappos, Ludwig
    Montalban, Xavier
    Guittari, Carol-Jean
    Koendgen, Harold
    Li, Carrie
    Marcillat, Carole
    Wormser, David
    Wolinsky, Jerry
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP13 - NP13
  • [44] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Hughes, R.
    McNamara, J.
    Pradhan, A.
    Wormser, D.
    Koendgen, H.
    Wolinsky, J. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 239 - 239
  • [45] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, Stephen
    Kappos, Ludwig
    Montalban, Xavier
    Chognot, Cathy
    Jessop, Nikki
    Kadner, Karen
    Pradhan, Ashish
    Incera, Elodie
    Wolinsky, Jerry
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 352 - 353
  • [46] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S.
    Kappos, L.
    Montalban, X.
    Chognot, C.
    Craveiro, L.
    Pradhan, A.
    Prajapati, K.
    Wolinsky, J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 306 - 306
  • [47] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Chognot, C.
    Jessop, N.
    Kadner, K.
    Pradhan, A.
    Prajapati, K.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 354 - 355
  • [48] Baseline Immunophenotyping and Gene Expression Analysis in Secondary Progressive Multiple Sclerosis Patients of Phase III EXPAND Trial
    Mao-Draayer, Yang
    Wu, Qi
    Wang, Qin
    Dowling, Catherine
    Mao, Guangmei
    Lundy, Steven K.
    Segal, Benjamin Matthew M.
    Wallstroem, Erik
    Fox, David A.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 68 - 68
  • [49] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Prajapati, K.
    Koendgen, H.
    Craveiro, L.
    Hughes, R.
    Pradhan, A.
    Wolinsky, J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 68 - 69
  • [50] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Koendgen, H.
    Li, C.
    Marcillat, C.
    Pradhan, A.
    Wormser, D.
    Wolinsky, J. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 334 - 334